Literature DB >> 26366337

Protective and Pathogenic Responses to Chikungunya Virus Infection.

Kristin M Long1, Mark T Heise2.   

Abstract

Chikungunya virus (CHIKV) is an arbovirus responsible for causing epidemic outbreaks of human disease characterized by painful and often debilitating arthralgia. Recently CHIKV has moved into the Caribbean and the Americas resulting in massive outbreaks in naïve human populations. Given the importance of CHIKV as an emerging disease, a significant amount of effort has gone into interpreting the virus-host interactions that contribute to protection or virus-induced pathology following CHIKV infection, with the long term goal of using this information to develop new therapies or safe and effective anti-CHIKV vaccines. This work has made it clear that numerous distinct host responses are involved in the response to CHIKV infection, where some aspects of the host innate and adaptive immune response protect from or limit virus-induced disease, while other pathways actually exacerbate the virus-induced disease process. This review will discuss mechanisms that have been identified as playing a role in the host response to CHIKV infection and illustrate the importance of carefully evaluating these responses to determine whether they play a protective or pathologic role during CHIKV infection.

Entities:  

Keywords:  Chikungunya virus; alphavirus; immunopathology; vaccine

Year:  2015        PMID: 26366337      PMCID: PMC4564112          DOI: 10.1007/s40475-015-0037-z

Source DB:  PubMed          Journal:  Curr Trop Med Rep


  110 in total

1.  Inhibition of host translation by virus infection in vivo.

Authors:  René Toribio; Iván Ventoso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013.

Authors:  S Cassadou; S Boucau; M Petit-Sinturel; P Huc; I Leparc-Goffart; M Ledrans
Journal:  Euro Surveill       Date:  2014-04-03

3.  Vectors of Chikungunya virus in Senegal: current data and transmission cycles.

Authors:  M Diallo; J Thonnon; M Traore-Lamizana; D Fontenille
Journal:  Am J Trop Med Hyg       Date:  1999-02       Impact factor: 2.345

4.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

5.  Chikungunya: a risk for Mediterranean countries?

Authors:  Marie Vazeille; Charles Jeannin; Estelle Martin; Francis Schaffner; Anna-Bella Failloux
Journal:  Acta Trop       Date:  2007-10-12       Impact factor: 3.112

6.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

Review 7.  Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.

Authors:  Laurence Dupuis-Maguiraga; Marion Noret; Sonia Brun; Roger Le Grand; Gabriel Gras; Pierre Roques
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

8.  Heat shock protein 90 positively regulates Chikungunya virus replication by stabilizing viral non-structural protein nsP2 during infection.

Authors:  Indrani Das; Itishree Basantray; Prabhudutta Mamidi; Tapas K Nayak; Pratheek B M; Subhasis Chattopadhyay; Soma Chattopadhyay
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

9.  Characterization of chikungunya virus-like particles.

Authors:  Nitchakarn Noranate; Naokazu Takeda; Prukswan Chetanachan; Pathompong Sittisaman; Atchareeya A-Nuegoonpipat; Surapee Anantapreecha
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

10.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10
View more
  14 in total

1.  Regulatory T cells and IL-10 as modulators of chikungunya disease outcome: a preliminary study.

Authors:  S P Kulkarni; M Ganu; P Jayawant; S Thanapati; A Ganu; A S Tripathy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-25       Impact factor: 3.267

Review 2.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

3.  Next generation sequencing of DNA-launched Chikungunya vaccine virus.

Authors:  Rachmat Hidajat; Brian Nickols; Naomi Forrester; Irina Tretyakova; Scott Weaver; Peter Pushko
Journal:  Virology       Date:  2016-02-06       Impact factor: 3.616

Review 4.  Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus.

Authors:  Muktha S Natrajan; Alejandra Rojas; Jesse J Waggoner
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

5.  Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.

Authors:  Natalie A Prow; Bing Tang; Joy Gardner; Thuy T Le; Adam Taylor; Yee S Poo; Eri Nakayama; Thiago D C Hirata; Helder I Nakaya; Andrii Slonchak; Pamela Mukhopadhyay; Suresh Mahalingam; Wayne A Schroder; William Klimstra; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-12-27       Impact factor: 6.823

6.  Complete Genome Sequences of 15 Chikungunya Virus Isolates from Puerto Rico.

Authors:  Wes A Sanders; Kristin Long; Brenda Rivera; Heather A Vincent; Mark T Heise; Jose F Rodriguez-Orengo; Nathaniel J Moorman
Journal:  Genome Announc       Date:  2017-07-06

7.  RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Authors:  Jane A C Wilson; Natalie A Prow; Wayne A Schroder; Jonathan J Ellis; Helen E Cumming; Linden J Gearing; Yee Suan Poo; Adam Taylor; Paul J Hertzog; Francesca Di Giallonardo; Linda Hueston; Roger Le Grand; Bing Tang; Thuy T Le; Joy Gardner; Suresh Mahalingam; Pierre Roques; Phillip I Bird; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-02-16       Impact factor: 6.823

8.  Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate.

Authors:  Yi-Hao Chan; Teck-Hui Teo; Age Utt; Jeslin Jl Tan; Siti Naqiah Amrun; Farhana Abu Bakar; Wearn-Xin Yee; Etienne Becht; Cheryl Yi-Pin Lee; Bernett Lee; Ravisankar Rajarethinam; Evan Newell; Andres Merits; Guillaume Carissimo; Fok-Moon Lum; Lisa Fp Ng
Journal:  EMBO Mol Med       Date:  2019-06       Impact factor: 12.137

Review 9.  Cellular and Molecular Immune Response to Chikungunya Virus Infection.

Authors:  Ithallo S B Tanabe; Eloiza L L Tanabe; Elane C Santos; Wanessa V Martins; Isadora M T C Araújo; Maria C A Cavalcante; Ana R V Lima; Niels O S Câmara; Leticia Anderson; Dinar Yunusov; Ênio J Bassi
Journal:  Front Cell Infect Microbiol       Date:  2018-10-10       Impact factor: 5.293

Review 10.  Disease Resolution in Chikungunya-What Decides the Outcome?

Authors:  Priyanshu Srivastava; Ankit Kumar; Abdul Hasan; Divya Mehta; Ramesh Kumar; Chetan Sharma; Sujatha Sunil
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.